{"title":"[钌配合物作为抗肿瘤药物:一种新的钌(III)与亚氨基二乙酸配合物的分离]。","authors":"R Vilaplana, M G Basallote, F González-Vilchez","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The authors discuss the convenience for using ruthenium complexes as potential antitumor drugs, and the considerable importance of these substances in regard to their biological activity. The synthesis of a new drug of the group and the results of its administration to mice bearing Ehrlich ascites cancer are reported.</p>","PeriodicalId":77791,"journal":{"name":"Revista espanola de oncologia","volume":"31 4","pages":"575-82"},"PeriodicalIF":0.0000,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Ruthenium complexes as antitumor drugs: isolation of a new Ru (III) and iminodiacetic acid complex].\",\"authors\":\"R Vilaplana, M G Basallote, F González-Vilchez\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The authors discuss the convenience for using ruthenium complexes as potential antitumor drugs, and the considerable importance of these substances in regard to their biological activity. The synthesis of a new drug of the group and the results of its administration to mice bearing Ehrlich ascites cancer are reported.</p>\",\"PeriodicalId\":77791,\"journal\":{\"name\":\"Revista espanola de oncologia\",\"volume\":\"31 4\",\"pages\":\"575-82\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1984-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista espanola de oncologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista espanola de oncologia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Ruthenium complexes as antitumor drugs: isolation of a new Ru (III) and iminodiacetic acid complex].
The authors discuss the convenience for using ruthenium complexes as potential antitumor drugs, and the considerable importance of these substances in regard to their biological activity. The synthesis of a new drug of the group and the results of its administration to mice bearing Ehrlich ascites cancer are reported.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
